according to a new study published in The New England Journal of Medicine. The immunotherapy protocol successfully treated 100% of rectal cancer patients involved in the trial. “My husband ...

according to a new study published in The New England Journal of Medicine. The immunotherapy protocol successfully treated 100% of rectal cancer patients involved in the trial. "My husband ...

In a groundbreaking clinical trial, immunotherapy alone eliminated rectal cancer in all 14 participants. This study, the ...

But the new study, published last week in the New England Journal of Medicine, found that the immunotherapy treatment worked against not only advanced rectal cancer but other cancer types too ...

But in 2024, she published encouraging results from a small study of people with rectal cancer, in which all 42 patients who got the checkpoint inhibitor, dostarlimab, as a monthly infusion became ...

Colon and rectal cancer disproportionately impact the Black community. A new study published in the Journal of Clinical Oncology suggests that a common over-the-counter drug may significantly ...

The results from an ambitious cancer ... study, which debuted at the same conference in 2022. During Phase 1, which was conducted in 2020, a tiny sample of 14 patients with early-stage rectal ...

A blood test intended to detect colorectal cancer performed well in a clinical study, a step towards expanding options for screening the potentially deadly disease. Published in the New England ...

A retrospective study of patients with distal rectal cancer at Memorial Sloan Kettering Cancer Center (MSK) has found a higher rate of local recurrence after intersphincteric resection with handsewn ...